treatment

November 14, 2024

New therapeutic approach for severe COVID-19: faster recovery and reduced mortality

An international study, with the participation of the University of Zaragoza and the Aragón Health Research Institute (IIS Aragón), has tested a new therapeutic strategy to treat severe COVID. It is a clinical trial whose results are published in eClinicalMedicine and which could also be applied to other respiratory viruses.
November 13, 2024

ASEICA organizes a “Week of Science in Cancer” with an international congress that will bring together 400 experts

The activities of the “Science Week” in Zaragoza will run from 12 to 16 November 2024. In addition to various informative days and meetings between patients and researchers, several grants will be awarded for cancer research worth a total of 345.000 euros.
October 14, 2024

A revolutionary transplant allows a diabetic patient to regain the ability to produce insulin

Scientists at Nankai University (China) have made a significant breakthrough in the treatment of type 1 diabetes, transforming fat cells into insulin-producing beta cells
6 May 2024

A research team launches a questionnaire to find out how cancer patients experienced the treatment of the disease

The European 4D PICTURE project investigates so that cancer patients reach shared decision-making moments with the best information and to do so it is necessary to know their experience during treatment.
November 27, 2023

A treatment that attacks two proteins at the same time opens the door to controlling the worst breast cancer

A new study has shown that the simultaneous inhibition of two different proteins may represent an effective new strategy to combat triple-negative breast cancer.
November 23, 2023

The ”la Caixa” Foundation promotes a project with the participation of the IIS Aragón for the early diagnosis and treatment of pancreatic cancer

Patricia Sancho, researcher at IIS Aragón, collaborates in one of the projects awarded with nearly one million euros to advance the early diagnosis of pancreatic cancer.